What's Next for Private Equity and Healthcare Investment

Healthcare Transactions attorney John Saran was interviewed on a HIMSS TV segment about what healthcare private equity investors can expect from government enforcement agencies in 2025. He explained that with the elections concluded and a second Trump Administration entering Washington, D.C., some clients anticipate a return to normalcy when it comes to deal-making, though many expect longer review periods and larger filing and documentation requirements thanks to new Hart-Scott-Rodino Act (HSR) antitrust rules set to take effect early next year. He added that what exactly will happen at the Federal Trade Commission (FTC) under new leadership remains to be seen, whereas states continue to undertake bipartisan efforts to study the effects of healthcare consolidations within specific territories and pass laws accordingly. The interview also covered other notable developments and trends, from the impact of fluctuating interest rates to the veto of California Assembly Bill (AB) 3129.

Duration: 14:44

Mr. Saran's interviewed was also reposted on Healthcare Finance, Healthcare IT News and MobiHealthNews.